OTCMKTS:LZAGY

Lonza Group - LZAGY Stock Forecast, Price & News

$44.83

+0.66 (+1.49%)

(As of 09/27/2022 12:00 AM ET)

Add

Compare

Today's Range: $44.54
▼
$45.60
50-Day Range: $44.17
▼
$61.61
52-Week Range: $43.85
▼
$85.18

Volume: 296,666 shs
Average Volume: 110,371 shs
Market Capitalization: $33.38 billion

P/E Ratio: N/A
Dividend Yield: 0.20%
Price Target: N/A

Lonza Group MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
0.00% of Shares Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: 22.52%
From $1.51 to $1.85 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.60 out of 5 stars

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Lonza Group.

5.0

Short Interest

Percentage of Shares Shorted
0.00% of the outstanding shares of Lonza Group have been sold short.
Short Interest Ratio / Days to Cover
Lonza Group has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Lonza Group has recently decreased by 58.70%, indicating that investor sentiment is improving significantly.

0.8

Dividend Strength

Dividend Yield
Lonza Group has a dividend yield of 0.20%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Lonza Group does not have a long track record of dividend growth.
Dividend Sustainability
Based on earnings estimates, Lonza Group will have a dividend payout ratio of 4.86% next year. This indicates that Lonza Group will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for LZAGY.

0.0

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 1 news article for Lonza Group this week, compared to 0 articles on an average week.
MarketBeat Follows
Only 1 people have added Lonza Group to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Lonza Group insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.07% of the stock of Lonza Group is held by insiders.
Percentage Held by Institutions
Only 0.08% of the stock of Lonza Group is held by institutions.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Lonza Group are expected to grow by 22.52% in the coming year, from $1.51 to $1.85 per share.
Price to Earnings Growth Ratio
Lonza Group has a PEG Ratio of 1.23. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Lonza Group has a P/B Ratio of 3.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Lonza Group (OTCMKTS:LZAGY) Stock

Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions. The Biologics division engages in the contract development and manufacturing services for biopharmaceuticals. The Small Molecules division operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. The Cell and Gene division develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies. It also offers contract development and manufacturing services for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment provides specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules and Health Ingredients division offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.

Receive LZAGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lonza Group and its competitors with MarketBeat's FREE daily newsletter.

LZAGY Stock News Headlines

September 6, 2022 | markets.businessinsider.com

Lonza and Touchlight collaborate on end-to-end mRNA offering

July 22, 2022 | finance.yahoo.com

Lonza's first-half core EBITDA gains 16.5%

July 22, 2022 | finance.yahoo.com

UPDATE 1-Lonza's first-half core EBITDA gains 16.5%

June 18, 2022 | seekingalpha.com

Lonza: One Stop Shop For Global Drug Manufacturing, At A Price

March 10, 2022 | seekingalpha.com

Lonza finishes laboratory expansion at API manufacturing facility in China

January 29, 2022 | seekingalpha.com

Lonza Group AG GAAP EPS of CHF39.52, revenue of CHF5.4B

January 27, 2022 | finance.yahoo.com

HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candidate

January 26, 2022 | ca.finance.yahoo.com

Lonza's full-year core EBITDA up 20.7% on vaccine demand

January 19, 2022 | nasdaq.com

Lonza Group AG ADR (LZAGY)

November 13, 2021 | finance.yahoo.com

Should You Have Lonza Stock on Your Watchlist?

July 27, 2021 | finance.yahoo.com

Moderna Slips As Issues At Partners Delay Overseas Release Of Shots

July 27, 2021 | finance.yahoo.com

UPDATE 2-Supply issues to delay Moderna COVID-19 vaccine shipments, S.Korea says

July 23, 2021 | finance.yahoo.com

RPT-UPDATE 2-Vaccine business helps Lonza lifts 2021 sales outlook

July 23, 2021 | finance.yahoo.com

Vaccine business helps Lonza lifts 2021 sales outlook

June 21, 2021 | finance.yahoo.com

Lonza Group Ag (LZAGY) Upgraded to Buy: What Does It Mean for the Stock?

May 17, 2021 | finance.yahoo.com

Gracell Biotechnologies Reports First Quarter 2021 Unaudited Financial Results and Provides Corporate Update

April 29, 2021 | finance.yahoo.com

Lonza says 3 Moderna vaccine ingredient lines to be at capacity by end-June

April 29, 2021 | finance.yahoo.com

UPDATE 2-Switzerland's Lonza to boost production for Moderna COVID-19 vaccine

April 27, 2021 | finance.yahoo.com

REFILE-Nestle staff sought to help Lonza production for Moderna vaccine -Swiss TV

April 19, 2021 | finance.yahoo.com

Herens Midco S.a.r.l. -- Moody's assigns B3 Corporate Family Rating to Herens Midco S.a.r.l.; outlook positive

April 19, 2021 | finance.yahoo.com

Herens HoldCo S.a.r.l. -- Moody's assigns B3 Corporate Family Rating to Herens Midco S.a.r.l.; outlook positive

April 18, 2021 | uk.finance.yahoo.com

Lonza Group Stock Shows Every Sign Of Being Significantly Overvalued

April 14, 2021 | finance.yahoo.com

aTyr Pharma Recruits Lonza As Manufacturing Partner For Cancer Therapy ATYR2810

April 12, 2021 | finance.yahoo.com

UPDATE 1-Spain's Rovi to make ingredients for Moderna's COVID-19 vaccine

March 15, 2021 | finance.yahoo.com

UPDATE 1-Lonza gets licence to make ingredients for Moderna vaccine

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive LZAGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lonza Group and its competitors with MarketBeat's FREE daily newsletter.

LZAGY Company Calendar

Today: 9/28/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Tobacco products
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:LZAGY
CUSIP: N/A
CIK: 1446711
Web: www.lonza.com
Phone: (161) 316-8111
Fax: 41-61-316-9111
Employees: 16,540
Year Founded: 1897

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: 29.69
P/E Growth: 1.23
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 0.23
Current Ratio: 2.51
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $5.92 billion
Price / Sales: 5.64
Cash Flow: $1.78 per share
Price / Cash Flow: 25.18
Book Value: $14.43 per share
Price / Book: 3.11

Miscellaneous

Outstanding Shares: 744,688,000
Free Float: 744,167,000
Market Cap: $33.38 billion
Optionable: Not Optionable
Beta: 0.98

Social Links

Key Executives

Dr. Pierre-Alain Ruffieux Ph.D. (Age 53)
Chief Exec. Officer
Comp: $2.71M

Mr. Philippe Deecke (Age 50)
Chief Financial Officer

Ms. Maria Soler Nunez
Head of Group Operations

Mr. Dirk Oehlers
VP of Investor Relations

Mr. Andreas Bohrer
Group Gen. Counsel & Company Sec.

Ms. Victoria Morgan
Head of External Communications

Ms. Jennifer Clancy
Sr. Director of Global Marketing

Dr. Caroline Barth M.D. (Age 50)
Chief HR Officer

Ms. Constance Ward
Head of External Communications

Dr. Sanna Fowler
Head of External Communications

Key Competitors

View All Competitors

LZAGY Stock - Frequently Asked Questions

Should I buy or sell Lonza Group stock right now?: 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Lonza Group in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" LZAGY shares.
View LZAGY analyst ratings or view top-rated stocks.
How have LZAGY shares performed in 2022?: Lonza Group's stock was trading at $83.50 at the beginning of 2022. Since then, LZAGY shares have decreased by 46.3% and is now trading at $44.8250.
View the best growth stocks for 2022 here.
Are investors shorting Lonza Group?: Lonza Group saw a decline in short interest in September. As of September 15th, there was short interest totaling 10,200 shares, a decline of 58.7% from the August 31st total of 24,700 shares. Based on an average daily volume of 195,700 shares, the short-interest ratio is presently 0.1 days.
View Lonza Group's Short Interest.
How often does Lonza Group pay dividends? What is the dividend yield for Lonza Group?: Lonza Group announced a dividend on Wednesday, May 4th. Stockholders of record on Tuesday, May 10th will be given a dividend of $0.0895 per share on Thursday, May 26th. This represents a dividend yield of 0.39%. The ex-dividend date of this dividend is Monday, May 9th.
Read our dividend analysis for LZAGY.
Is Lonza Group a good dividend stock?: Lonza Group (OTCMKTS:LZAGY) pays an annual dividend of $0.09 per share and currently has a dividend yield of 0.20%.
Read our dividend analysis for LZAGY.

What is Lonza Group's stock symbol?: Lonza Group trades on the OTCMKTS under the ticker symbol "LZAGY."
How do I buy shares of Lonza Group?: Shares of LZAGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Lonza Group's stock price today?: One share of LZAGY stock can currently be purchased for approximately $44.83.
How much money does Lonza Group make?: Lonza Group (OTCMKTS:LZAGY) has a market capitalization of $33.38 billion and generates $5.92 billion in revenue each year.
How many employees does Lonza Group have?: The company employs 16,540 workers across the globe.
Does Lonza Group have any subsidiaries?: The following companies are subsidiares of Lonza Group: Arch Acquisition LLC, Arch Chemicals Canada Inc., Arch Chemicals Inc., Arch Chemicals Limited, Arch Chemicals Receivables LLC, Arch Chemicals SAS, Arch Personal Care Products L.P., Arch Protection Chemicals Private Limited, Arch Quimica Argentina S.R.L., Arch Quimica Brasil Ltda., Arch Timber Protection B.V., Arch Treatment Technologies Inc., Arch UK Biocides Limited, Arch Water Products France S.A.S., Arch Water Products South Africa (Pty) Ltd, Arch Wood Protection (Aust) Pty Ltd, Arch Wood Protection (M) Sdn. Bhd., Arch Wood Protection (NZ) Limited, Arch Wood Protection (SA) Pty Ltd, Arch Wood Protection Canada Corp., Arch Wood Protection Inc, Bend Research Inc., BioAtrium AG, CH Capsules Malaysia SDN BHD, Capsugel, Capsugel (Thailand) Co. Ltd, Capsugel Australia Pty Ltd, Capsugel Belgium NV, Capsugel Brasil Importação e Distribuição de Insumos Farmacêuticos e Alimentos Ltda., Capsugel Canada Corp., Capsugel Distribucion S. de R.L. de C.V., Capsugel FinanceCo II S.à r.l., Capsugel FinanceCo S.C.A., Capsugel FinanceCo S.à r.l, Capsugel France Holdings SAS, Capsugel France SAS, Capsugel Funding LLC, Capsugel Germany GmbH, Capsugel Healthcare Private Limited, Capsugel Holdings (Hong Kong) Limited, Capsugel Holdings S.à r.l., Capsugel Holdings US Inc., Capsugel Hungary Kft, Capsugel Inc., Capsugel Italy S.R.L., Capsugel Japan Inc., Capsugel Manufacturing Inc., Capsugel Middle East Sàrl, Capsugel New Zealand Limited, Capsugel Pharmaceutical and Health Products Marketing Ltd, Capsugel Philippines Inc., Capsugel Ploermel SAS, Capsugel S.à r.l., Capsugel Spain S.L., Capsugel US LLC, Capsugel de México S. de R.L. de C.V., Diacon Technologies, Diacon Technologies Limited, Hickson Ltd, InterHealth Nutraceuticals, InterHealth Nutraceuticals Incorporated, LLC Capsugel, Lonza (China) Investments Co. Ltd., Lonza AG, Lonza America Inc., Lonza Argentina S.A, Lonza Biologics Inc., Lonza Biologics Porriño S.L., Lonza Biologics Tuas Pte. Ltd, Lonza Biologics plc, Lonza Bioscience SARL, Lonza Bioscience Singapore Pte Ltd, Lonza Biotec s.r.o., Lonza Cologne GmbH, Lonza Colombia S.A.S, Lonza Copenhagen ApS, Lonza Costa Rica S.A., Lonza Geleen B.V., Lonza Guangzhou Ltd, Lonza Guangzhou Nansha Ltd, Lonza Houston Inc., Lonza Inc., Lonza India Private Limited, Lonza Israel Ltd, Lonza Japan Ltd, Lonza Luxembourg S.à r.l., Lonza Microbial Control Asia Pacific Pte Ltd, Lonza Milano S.r.l., Lonza NZ Limited, Lonza Nanjing Ltd, Lonza Netherlands B.V, Lonza Rockland Inc., Lonza Sales AG, Lonza Shanghai International Trading Ltd, Lonza Suzhou Ltd, Lonza Swiss Finanz AG, Lonza Swiss Licences AG, Lonza Verviers SPRL, Lonza Walkersville Inc., Lonza do Brasil Especialidades Quimicas Ltda., MW Encap (Holdings) Limited, MW Encap Limited, Micro-Macinazione, Micro-Macinazione SA, Octane Biotech, Octane Biotech Inc, P.T. Capsugel Indonesia, PharmaCell, Powdersize LLC, Suzhou Capsugel Limited (JV), Triangle Research Labs, Xcelience Clinical Services Ltd, Xcelience LLC, and Zelam Holdings.
Read More
How can I contact Lonza Group?: Lonza Group's mailing address is Muenchensteinerstrasse 38, Basel V8, 4002. The official website for the company is www.lonza.com. The company can be reached via phone at (161) 316-8111, via email at investor.relations@lonza.com, or via fax at 41-61-316-9111.

This page (OTCMKTS:LZAGY) was last updated on 9/28/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Lonza Group - LZAGY Stock Forecast, Price & News

Lonza Group MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month